Latest News and Press Releases
Want to stay updated on the latest news?
-
DANVERS, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 25...
-
DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an...
-
DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new...
-
DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received an...
-
マサチューセッツ州ダンバース及びサンフランシスコ発 , Feb. 02, 2018 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダーであるアビオメッド (Abiomed, Inc.、NASDAQ:ABMD) は本日、2018年度第3四半期に1億5,400万ドル (約168億9,000万円)...
-
U.S. Patient Utilization Grew 33%, Year Over Year DANVERS, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery...
-
DANVERS, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, February 1, 2018, the Company will release financial results for the third quarter of fiscal...
-
米国マサチューセッツ州ダンバースおよびサンフランシスコ発, Jan. 09, 2018 (GLOBE NEWSWIRE) -- アビオメッド、2018年度第３四半期の概算収益を発表、前年度比34%増の1億5,400万ドル 2018年1月8日、米国マサチューセッツ州ダンバースおよびサンフランシスコ発（グローブニューズワイヤ） --...
-
DANVERS, Mass. and SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported preliminary, unaudited,...
-
DANVERS, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...